Cell Separation Technologies Market size is anticipated to witness a major upsurge from 2022 to 2028. This is due to the rising application scope of isolated cells in life science research, enabling scientists to conduct molecular and epigenetic analysis. Likewise, the significant increase in biotech research and development activities will further augment the need for cell isolation kits and other separation devices over the forecast spell. Cell separation, also known as cell sorting or cell isolation, refers to the process of isolating one or more specific cell populations from the heterogeneous cell mixture. Cell separation techniques can be performed in a range of complex biological samples, such as leukapheresis products and whole peripheral blood.
Dramatic increase in the incidence of cancer and the emergence of cell-based therapy as a flourishing research field to alleviate medical conditions will impel the market trends. Various research institutes, including the Memorial Sloan Kettering Cancer Center, have been consistently investigating an array of cell types for novel therapeutic uses, including the treatment of blood cancers. Such factors, alongside the advances in mesenchymal stem cells and other cell-based therapies, will further push the demand for stem cell separation technologies in the coming years.
Fluorescence activated cell sorting (FACS) will emerge as a prominent technology segment for the cell separation technologies industry by 2028. The segment expansion is driven by the increased versatility of the FACS technology, as it can separate cells based on physical characteristics like granularity as well as surface markers. Owing to the high throughput, the technology has also become a standard in multiple clinical and research labs, thus proliferating the requirement of cell sorting techniques.
The Europe cell separation technologies market will depict commendable growth through 2028, on account of the growing number of research laboratories in the region. In 2021, AstraZeneca launched a new $1.3 billion research facility in the UK, designed to work on the development of next-generation therapeutics including cell therapies. Such developments, along with the rising prevalence of cancer and the rapid investment of UK-based biotech companies to boost the drug discovery process, will also amplify the regional growth during the forecast timeframe.
Key industry players include EMD Millipore, PerkinElmer, GE Healthcare, ZEISS, Thermo Fisher Scientific, Miltenyi Biotec, Bio-Rad Laboratories, STEMCELL Technologies, and Akadeum Life Sciences, among others. Innovative product launches, collaborations, and acquisitions are among the initiatives being undertaken by these industry participants to drive their presence in the competitive market.
For example, in October 2021, PerkinElmer, Inc. announced the commercial launch of the HIVE scRNAseq Solution in collaboration with Honeycomb Biotechnologies, Inc., designed for single-cell isolation and analysis. In February 2021, Thermo Fisher Scientific Inc. announced the acquisition of the cell sorting technology assets, Bigfoot Spectral Cell Sorter, from Propel Labs, to bring more innovative sorting capabilities, novel safety features, and faster throughput.
Scientists and early-career researchers have witnessed unprecedented impacts of the novel coronavirus pandemic worldwide. The global health emergency led to the shutdown of various scientific research laboratories at its peak, which may have created a negative impact on the steady expansion of the industry. Despite these setbacks, the rising prominence of cell sorting techniques to gain a better understanding of the rapid spread of coronavirus may aid industry recovery. Scientists are increasingly focusing on the sorting of virus-infected cells for the development of anti-coronavirus drugs. This potential application of cell separation techniques during the pandemic could boost the industry share in the coming years.
Market, By Technology
Market, By Application
Market, By Product
Market, By End-use
The above information is provided for the following regions and countries: